American Journal of Pharmacology and Toxicology

Immunotherapy: Understanding Safety and Pharmacology

Description

Cancer immunotherapy attempts to stimulate the immune system to destroy cancer cells. Recently Immunotherapy became of great interest to the scientific community, since it was found particularly promising to treat cancer and it represents the most targeted therapy of all. Authors offering original research articles, review papers featuring timely issues or topics are invited to submit. Topics spanning immunotherapy may include but are not limited to: Antibody-based therapy to treat cancer. CAR T-Cell Therapies. Immune checkpoint inhibitors to treat cancer. Cancer vaccines. Editors encourage discussion on evaluation of safety and pharmacology of immunotherapy.

Guest Editors

NameAffiliation
Miriam CanaveseScientific Director and Head of Immuno-Pharmacology, Freeline Therapeutics, UK
Micaela HarrasserResearcher, University College London, UK

Important Dates

Manuscript Submission DeadlineAugust 31, 2020
Review Completed byOctober 15, 2020
Possible Publication DateNovember 30, 2020